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a b s t r a c t
Pterosin B is a naturally occurring indanone found in bracken fern (Pteridium aquilinum) that displays a
variety of interesting pharmacological properties, but for which few stereoselective syntheses exist.
Herein we describe a 7-step stereoselective synthesis of (2R)-pterosin B via 6-bromo-5,7-dimethylin-
dan-1-one whose structure was confirmed by NOE analysis and structure determination by X-ray crys-
tallography. The hydroxyethyl chain was introduced via a Suzuki-Miyaura cross-coupling reaction. The
2-methyl group was introduced stereoselectively by methylation of a SAMP [(S)-1-amino-2-methoxy-
methyl)pyrrolidine] hydrazone and the chiral auxiliary was removed to produce (2R)-pterosin B. The
structure of pterosin B was confirmed by specific rotation and structural determination by X-ray
crystallography.
Crown Copyright  2018 Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Pterosins are a group of substituted 1-indanones originally
characterized following their isolation from the bracken fern
Pteridium aquilinum [1–3]. Pterosin B (1) occurs naturally as its
(2R) isomer and is a decomposition product of the bracken toxin
ptaquiloside (2) (Fig. 1). Ptaquiloside is a norsesquiterpene glu-
coside natural product of the illudane type. Under alkaline
conditions, ptaquiloside loses glucose forming an unstable acylful-
vene-type compound which subsequently decomposes to form
pterosin B [4–6].
Pterosin B displays several interesting pharmacological proper-
ties, for example in the treatment of diabetes, obesity [4,7] and
osteoarthritis [8]. Unfortunately, typical concentrations of pterosin
B in bracken are very low and most chemical syntheses provide
only the racemic form [9,10]. A short stereoselective synthesis of
pterosin B is therefore highly desirable.
Recently (2R)-pterosin B has been prepared in 13 steps from
2-(4-bromo-2,6-dimethylphenyl)ethanol [11]. A key step in this
synthesis involves an asymmetric intramolecular aldol reaction
of compound 3 to produce 4 (syn/anti = 98:2, 85% ee) (Fig. 2).
Subsequently, compound 4 was converted into (2R)-pterosin B in
3 steps. As an alternative, more concise route to (2R)-pterosin B,
we envisaged elaboration of the core indanone structure 5
(Fig. 2), described previously by Sheriden and co-workers [12]
and describe herein a stereoselective 7-step synthesis of (2R)-pter-
osin B and its characterisation by X-ray crystallography.
Results and discussion
Our initial attempts towards the synthesis of 5, involving the
Friedel-Crafts acylation of 2-bromo-1,3-xylene using 3-chloropro-
pionyl chloride, produced an inseparable mixture of the regioiso-
mers 6a and 6b (Scheme 1). This finding has also been reported
by Hsu and co-workers [13] in their synthesis of pterosin A. The
1H NMR spectrum of the mixture revealed a 2.5:1 ratio of products
6a and 6b, respectively, based on the signals for the aromatic ring
protons.
Heating the mixture of 6a and 6b in concentrated sulfuric acid
resulted in cyclisation to produce a mixture containing indanones
5 and 7. The 1H NMR spectrum of the mixture displayed singlets at
7.49 and 7.22 ppm, corresponding to the aromatic protons of the
respective indanones 7 and 5, in agreement with the literature
[13]. The relative amounts of the two isomers corresponded to that
prior to cyclisation, with 5 being the major product and being pro-
duced in a 2.5:1 ratio to 7. After silica column chromatography and
recrystallisation from ethyl acetate, 5 was obtained in 22% yield
from bromoxylene. The identity of 5was further confirmed by both
NOESY NMR (NOEs to H-4 and H-2 were observed upon irradiation
of H3) (Fig. 3) and X-ray crystallography [14] (ESI Fig. 1).
A variety of approaches have been used previously for introduc-
ing the hydroxyethyl group. McMorris and co-workers [15] reacted
the Grignard reagent of 2-bromo-1,3-xylene with oxirane. Follow-
ing acetylation of the hydroxyethyl group, the indanone ring was
constructed using a Friedel Crafts acylation with chloropropionyl
chloride followed by an acid-catalysed cyclisation [12,15]. In con-
trast, Farrell and co-workers reported the first example of a Pd-
catalysed method in which a 6-bromoindanone was employed in
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a Heck reaction with vinyl acetate in the synthesis of pterosin Z
[16]. This cross-coupling reaction gave a 1:1 mixture of E and Z iso-
mers in 29% yield together with a 6-vinyl indanone by-product.
Reduction and de-acetylation afforded the hydroxyethyl side
chain. More recently a Suzuki-Miyaura reaction was used to pro-
duce a 6-vinylated indanone precursor of pterosin A. Unfortunately
this could not be resolved from the reduced (6H) by-product. The
hydroxyethyl group was obtained following subsequent hydrobo-
ration [13].
In the synthesis of pterosin B we sought to introduce the
hydroxyethyl group directly onto indanone 5 using a Suzuki-
Miyaura cross-coupling with the benzyl-protected trifluoroborate
salt 8 [17]. Thus, cross-coupling of 8 with compound 5 afforded
indanone 9 in 54% yield (Scheme 2).
A variety ofmethods for asymmetric enolate alkylation are avail-
able [18,19] for achieving selective methylation of 9. These include
well-established procedures using Enders’ chiral hydrazone (SAMP/
RAMP)methodology [20–22] or via chiralN-amino cyclic carbamate
(AAC) hydrazones [23]. We elected to use Enders’ methodology due
to the ready availability of the chiral auxiliary and the expectation
that the methylated diastereomeric hydrazones would be resolv-
able. To introduce the methyl group with the correct R-configura-
tion, delivery to the bottom face of the aza-enolate requires the
use of SAMP. Thus compound 9was converted to its corresponding
SAMP hydrazone 10 by heating at reflux with SAMP and PTSA in
toluene in the presence of molecular sieves. Methylation of 10 was
achieved by treatment with LDA in THF at 78 C followed by the
addition of iodomethane. This provided 11 as a mixture of
diastereoisomers following silica column chromatography.
Although we were unable to separate these two diastereoisomers
using silica chromatography, they could be fully resolved by
reversed-phase HPLC (RP-HPLC) using an isocratic elution of
water/acetonitrile (15/85) (ESI Fig. 2)). Based on HPLC analysis a d.
r. of 85:15 in favour of the 2R diastereoisomer (11) was obtained.
Following purification by RP-HPLC, 11 was obtained in 61% yield.
To remove the chiral auxiliary from 11we investigated using O3
in CH2Cl2 as described previously [24,25]. During our initial
attempts to obtain the benzylated indanone 12 (Scheme 3) by
ozonolysis, we found that the desired product contained small
amounts of a contaminant that was isolated by RP-HPLC. This
was subsequently identified by 1H NMR and mass spectrometry
as the benzoylated compound 13. However, by using a low flow
of ozone, short reaction times and low temperature, oxidation of
the benzyl group could be minimized. Removal of the benzyl group
from 12 by catalytic hydrogenation using an H-Cube afforded
(2R)-pterosin B as a single enantiomer in 68% yield following final
purification by RP-HPLC.
Figure 1. Structures of pterosin B (1) and ptaquiloside (2).
Figure 2. Synthetic precursors to pterosin B.
Scheme 1. Friedel-Crafts acylation of 2-bromo-1,3-xylene to produce an insepara-
ble mixture of isomers 6a and 6b.
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Figure 3. Structures of indanones 5 and 7 and observed NOE interactions in the 1H
NMR of 5.
Scheme 2. Suzuki-Miyaura cross-coupling, and methylation of SAMP hydrazone.
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Scheme 3. Completion of the synthesis of (2R)-pterosin B (1).
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We also investigated whether the benzoylated indanone 13
could be successfully converted into pterosin B. Although removal
of the benzoyl group using aqueous ammonia resulted in the
expected racemization (as evidenced by chiral phase HPLC, ESI
Fig. 3), de-acylation could be achieved without loss of stereochem-
istry using an esterase from Bacillus subtilis (ESI Fig. 3).
Crystallisation of (R)-pterosin B (1) from amixture of chloroform
and hexane provided a sample with an ee of 100%, identical specific
rotation to that described in the literature [11] and permitted con-
firmation of its structure by X-ray crystallography (Fig. 4) [26].
Conclusion
In conclusion we have developed a concise stereoselective syn-
thesis of the naturally occurring (R)-enantiomer of pterosin B in
7-steps from commercially available 2-bromo-1,3-xylene. The
ready availability of (R)-pterosin will enable further evaluation of
its biological properties.
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